Orthocell Ltd (AU:OCC) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Orthocell Ltd is expanding its international presence with the appointment of Device Technologies Asia as the exclusive distributor for its nerve repair device, Remplir™, in Singapore. This move follows successful sales growth in Australia and New Zealand and marks Singapore as the first major market outside these regions. With strong financial backing and strategic partnerships, Orthocell is poised to achieve significant revenue growth and surgeon adoption in 2025.
For further insights into AU:OCC stock, check out TipRanks’ Stock Analysis page.